Total 2 articles
Analyzing the critical Venezuela Maduro capture change in 2026, focusing on the power vacuum, military response, and economic reconstruction.
AstraZeneca's $100 million upfront payment to China's Jacobio Pharma for a novel drug signals a major shift. The deal shows China's evolution from a generics maker to a key source of pharma innovation.
Advertise with Us
